109 related articles for article (PubMed ID: 19006181)
1. Bone inflammation and altered gene expression with type I diabetes early onset.
Motyl KJ; Botolin S; Irwin R; Appledorn DM; Kadakia T; Amalfitano A; Schwartz RC; McCabe LR
J Cell Physiol; 2009 Mar; 218(3):575-83. PubMed ID: 19006181
[TBL] [Abstract][Full Text] [Related]
2. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways.
Botolin S; McCabe LR
J Cell Biochem; 2006 Oct; 99(2):411-24. PubMed ID: 16619259
[TBL] [Abstract][Full Text] [Related]
3. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
Motyl KJ; Raetz M; Tekalur SA; Schwartz RC; McCabe LR
Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1250-60. PubMed ID: 21346244
[TBL] [Abstract][Full Text] [Related]
4. The bone marrow microenvironment contributes to type I diabetes induced osteoblast death.
Coe LM; Irwin R; Lippner D; McCabe LR
J Cell Physiol; 2011 Feb; 226(2):477-83. PubMed ID: 20677222
[TBL] [Abstract][Full Text] [Related]
5. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
[TBL] [Abstract][Full Text] [Related]
6. Is there an autoimmune process in bone? Gene expression studies in diabetic and nondiabetic BB rats as well as BB rat-related and -unrelated rat strains.
Klöting N; Follak N; Klöting I
Physiol Genomics; 2005 Dec; 24(1):59-64. PubMed ID: 16189279
[TBL] [Abstract][Full Text] [Related]
7. Administration of 5-androstenediol to mice: pharmacokinetics and cytokine gene expression.
Singh VK; Grace MB; Jacobsen KO; Chang CM; Parekh VI; Inal CE; Shafran RL; Whitnall AD; Kao TC; Jackson WE; Whitnall MH
Exp Mol Pathol; 2008 Apr; 84(2):178-88. PubMed ID: 18262521
[TBL] [Abstract][Full Text] [Related]
8. The alpha-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes.
Fukaya N; Mochizuki K; Shimada M; Goda T
Nutrition; 2009 Jun; 25(6):657-67. PubMed ID: 19216056
[TBL] [Abstract][Full Text] [Related]
9. Understanding the pathology and mechanisms of type I diabetic bone loss.
McCabe LR
J Cell Biochem; 2007 Dec; 102(6):1343-57. PubMed ID: 17975793
[TBL] [Abstract][Full Text] [Related]
10. Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice.
Motyl KJ; McCabe LR
J Cell Physiol; 2009 Feb; 218(2):376-84. PubMed ID: 18932203
[TBL] [Abstract][Full Text] [Related]
11. Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats.
Kanth VR; Lavanya K; Srinivas J; Raju TN
Curr Eye Res; 2009 Apr; 34(4):274-81. PubMed ID: 19373575
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin attenuates tibial bone loss in rats with type 1 diabetes and periodontitis.
Kim AR; Kim JH; Kim A; Sohn Y; Cha JH; Bak EJ; Yoo YJ
J Transl Med; 2018 Nov; 16(1):306. PubMed ID: 30413166
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
Botolin S; McCabe LR
J Cell Physiol; 2006 Dec; 209(3):967-76. PubMed ID: 16972249
[TBL] [Abstract][Full Text] [Related]
14. Time point is important for effects of syngeneic bone marrow transplantation for type 1 diabetes in mice.
Wen Y; Ouyang J; Li W; Chen J; Liu Y; Meng L; Zhang H; Zhou X
Transplant Proc; 2009 Jun; 41(5):1801-7. PubMed ID: 19545732
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
16. Caspase-2 deficiency protects mice from diabetes-induced marrow adiposity.
Coe LM; Lippner D; Perez GI; McCabe LR
J Cell Biochem; 2011 Sep; 112(9):2403-11. PubMed ID: 21538476
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.
Coe LM; Tekalur SA; Shu Y; Baumann MJ; McCabe LR
J Cell Physiol; 2015 Aug; 230(8):1944-53. PubMed ID: 25641511
[TBL] [Abstract][Full Text] [Related]
18. Low dose aspirin therapy decreases blood glucose levels but does not prevent type i diabetes-induced bone loss.
Coe LM; Denison JD; McCabe LR
Cell Physiol Biochem; 2011; 28(5):923-32. PubMed ID: 22178944
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional dysregulation of skeletal muscle protein metabolism in streptozotocin-diabetic mice.
Wieteska-Skrzeczynska W; Grzelkowska-Kowalczyk K; Jank M; Maciejewski H
J Physiol Pharmacol; 2009 May; 60 Suppl 1():29-36. PubMed ID: 19609011
[TBL] [Abstract][Full Text] [Related]
20. Strain-dependent increases in retinal inflammatory proteins and photoreceptor FGF-2 expression in streptozotocin-induced diabetic rats.
Kirwin SJ; Kanaly ST; Linke NA; Edelman JL
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5396-404. PubMed ID: 19474406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
